Log In
BCIQ
Print this Print this
 

SKL-NP (SKL11197)

  Manage Alerts
Collapse Summary General Information
Company SK Biopharmaceuticals Co. Ltd.
DescriptionNon-sedating analgesic
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat diabetic neuropathic pain (DNP)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today